InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Seres Therapeutics, Inc.

MCRB Clue Score46
United States Fiscal year ends December CIK 0001609809 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

22
Insider
Date
Role
Action
Shares
Price
Amount
Kelly Brady
18 May 2026
See Remarks
Sell
59
$7.53
$444.27
David S. Ege
28 Apr 2023
See Remarks
Sell
7,038
$5.19
$36.53K
David S. Ege
31 Oct 2022
See Remarks
Sell
5,012
$7.93
$39.75K
Marcus Chapman
22 Nov 2019
See Remarks
Sell
3,400
$3.91
$13.30K
Eric D. Shaff
28 Jan 2019
See Remarks
Sell
4,378
$5.75
$25.19K
Thomas DesRosier
28 Jan 2019
Chief Legal Officer and EVP
Sell
5,471
$5.75
$31.48K
John G. Aunins
17 Dec 2018
Chief Technology Officer & EVP
Sell
14,282
$6.39
$91.31K
John G. Aunins
15 Nov 2018
See Remarks
Sell
14,279
$8.26
$117.91K
John G. Aunins
15 Oct 2018
See Remarks
Sell
14,279
$5.94
$84.80K
John G. Aunins
17 Sep 2018
See Remarks
Sell
14,279
$7.27
$103.88K
Roger Pomerantz
7 Sep 2018
President and CEO
Sell
1,810
$9.00
$16.29K
Roger Pomerantz
6 Sep 2018
President and CEO
Sell
3,013
$9.04
$27.24K
Roger Pomerantz
5 Sep 2018
President and CEO
Sell
9,505
$9.12
$86.71K
John G. Aunins
15 Aug 2018
See Remarks
Sell
14,279
$7.57
$108.07K
John G. Aunins
15 Jul 2018
Chief Technology Officer & EVP
Sell
14,279
$8.10
$115.73K
Roger Pomerantz
22 Jun 2018
President and CEO
Sell
40,057
$9.36
$374.76K
Roger Pomerantz
21 Jun 2018
President and CEO
Sell
18,987
$9.06
$172.09K
Roger Pomerantz
20 Jun 2018
President and CEO
Sell
26,492
$9.33
$247.05K
John G. Aunins
15 Jun 2018
Chief Technology Officer & EVP
Sell
14,279
$8.57
$122.33K
John G. Aunins
15 May 2018
See Remarks
Sell
14,279
$8.08
$115.40K
Roger Pomerantz
9 May 2018
President and CEO
Sell
233
$9.00
$2.10K
John G. Aunins
25 Apr 2018
Chief Technology Officer & EVP
Sell
14,279
$7.58
$108.27K
Show all 112 transactions →

What was left out

Form 4 filings counted 278
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 51
Sales straight out of an exercise 33
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 9,854,506
Sales filed before the plan box existed 20
History held since 29 Jun 2015